| Primary |
| Glaucoma |
30.1% |
| Product Used For Unknown Indication |
25.4% |
| Hypertension |
10.1% |
| Intraocular Pressure Increased |
9.1% |
| Supplementation Therapy |
4.9% |
| Blood Cholesterol Increased |
4.1% |
| Dry Eye |
2.5% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Cardiac Disorder |
1.4% |
| Hypothyroidism |
1.4% |
| Intraocular Pressure Test |
1.4% |
| Open Angle Glaucoma |
1.4% |
| Diabetes Mellitus |
1.2% |
| Asthma |
1.0% |
| Blood Cholesterol |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Arthritis |
0.8% |
| Eye Lubrication Therapy |
0.8% |
| Blood Pressure |
0.6% |
| Hypersensitivity |
0.6% |
|
| Vision Blurred |
17.9% |
| Ocular Hyperaemia |
10.7% |
| Scleral Hyperaemia |
8.3% |
| Somnolence |
7.1% |
| Eye Pain |
6.0% |
| Lacrimation Increased |
6.0% |
| Muscular Weakness |
6.0% |
| Eye Irritation |
4.8% |
| Eye Pruritus |
3.6% |
| Intraocular Pressure Increased |
3.6% |
| Photophobia |
3.6% |
| Thirst |
3.6% |
| Disorientation |
2.4% |
| Eye Infection |
2.4% |
| Fatigue |
2.4% |
| Foreign Body Sensation In Eyes |
2.4% |
| Headache |
2.4% |
| Heart Rate Decreased |
2.4% |
| Heart Rate Increased |
2.4% |
| Instillation Site Pain |
2.4% |
|
| Secondary |
| Glaucoma |
30.7% |
| Product Used For Unknown Indication |
27.9% |
| Hypertension |
11.4% |
| Intraocular Pressure Increased |
7.1% |
| Blood Cholesterol |
2.9% |
| Diabetes Mellitus |
2.1% |
| Osteoporosis |
2.1% |
| Sleep Disorder |
2.1% |
| Age-related Macular Degeneration |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Cardiac Disorder |
1.4% |
| Dermatitis Contact |
1.4% |
| Multiple Fractures |
1.4% |
| Supplementation Therapy |
1.4% |
| Vitamin Supplementation |
1.4% |
| Diuretic Therapy |
0.7% |
| Eye Pain |
0.7% |
| Hepatic Cancer |
0.7% |
| Nutritional Supplementation |
0.7% |
| Preventive Surgery |
0.7% |
|
| Vision Blurred |
14.8% |
| Scleral Hyperaemia |
11.1% |
| Heart Rate Decreased |
7.4% |
| Somnolence |
7.4% |
| Dark Circles Under Eyes |
3.7% |
| Dry Eye |
3.7% |
| Erythema Of Eyelid |
3.7% |
| Fatigue |
3.7% |
| Inappropriate Schedule Of Drug Administration |
3.7% |
| Intraocular Pressure Increased |
3.7% |
| Muscular Weakness |
3.7% |
| Ocular Hyperaemia |
3.7% |
| Rhinorrhoea |
3.7% |
| Scleritis |
3.7% |
| Sensation Of Foreign Body |
3.7% |
| Skin Hyperpigmentation |
3.7% |
| Skin Irritation |
3.7% |
| Swelling Face |
3.7% |
| Thirst |
3.7% |
| Ulcer |
3.7% |
|
| Concomitant |
| Glaucoma |
28.6% |
| Product Used For Unknown Indication |
16.1% |
| Dry Eye |
12.5% |
| Hypersensitivity |
7.1% |
| Blood Cholesterol Increased |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Eye Inflammation |
3.6% |
| Intraocular Pressure Increased |
3.6% |
| Arthritis |
1.8% |
| Conjunctivitis Allergic |
1.8% |
| Cystoid Macular Oedema |
1.8% |
| Dry Eyes |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hormone Replacement Therapy |
1.8% |
| Hypotrichosis |
1.8% |
| Inflammation |
1.8% |
| Nephrolithiasis |
1.8% |
| Osteopenia |
1.8% |
| Post Procedural Complication |
1.8% |
| Postoperative Care |
1.8% |
|
| Eye Irritation |
18.8% |
| Lacrimation Increased |
12.5% |
| Ocular Hyperaemia |
12.5% |
| Scleral Hyperaemia |
12.5% |
| Eye Pain |
6.3% |
| Growth Of Eyelashes |
6.3% |
| Madarosis |
6.3% |
| Scleral Discolouration |
6.3% |
| Vision Blurred |
6.3% |
| Visual Impairment |
6.3% |
| Wrong Technique In Drug Usage Process |
6.3% |
|
